Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
indium (111In) hydroxyquinoline, Quantity: 0.01 microgram/mL (Equivalent: indium (111In) chloride, Qty 37 MBq/mL)
GE Healthcare Australia Pty Ltd
Injection, solution
Excipient Ingredients: water for injections; sodium chloride; hepes; oxyquinoline; polysorbate 80
Intravenous
1mL
Not scheduled. Not considered by committee
For in vitro radiolabelling of separated leucocytes and platelets which are subsequently reinjected intravenously for investigative purposes using appropriate imaging/counting procedures.
Visual Identification: Clear colourless or faint straw coloured solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 5 Days; Container Temperature: Store between 15-25 degrees Celsius
Registered
1992-05-04
1-020605 INDIUM [111IN] OXINE SOLUTION _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some common questions about Indium [ 111 In] Oxine solution.. It does not contain all the available information, nor does it take the place of talking to your doctor or treatment provider. All medicines have risks and benefits. Your doctor has weighed the risks of you being treated with Indium [ 111 In] Oxine solution against the expected benefits. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS PREPARATION, ASK YOUR DOCTOR OR TREATMENT PROVIDER. KEEP THIS LEAFLET. You may need to read it again. WHAT INDIUM [111IN] OXINE SOLUTION IS USED FOR Indium [ 111 In] Oxine solution is a radiopharmaceutical which is a medicinal product containing a small amount of radioactivity. Such radiopharmaceuticals are given in small amounts to find out or rule out a disease. A sample of your blood will be taken and mixed with the product to label some of the blood cells with radioactivity. This blood sample will be re-injected into your body to help to find infections such as abcesses in your abdomen, infections inside your bones and other types of infections and conditions. The radiation that your body receives is very low and is considered safe. The labelled blood cells circulate in the body and may temporarily collect in a particular area of tissue. The radioactivity can be detected from outside the body using special cameras, and a picture, known as a scan, can be taken. This scan will show the distribution of the radioactivity within your body. This can give the doctor valuable information about the location of inflammation or possible tissue damage or disease Your doctor will explain for which particular purpose he/she is using Indium [ 111 In] Oxine solution. Indium [ 111 In] Oxine solution is used to find out or rule out a diagnosis only. It is not used to treat or cure a disease. Ask your doctor if you have any questions about why Indium [ 111 In] Oxine solution has been prescribed for you. BEFORE YOU ARE G Read the complete document
11. Withdraw half the volume (~2.5 mL) of the platelet-poor plasma prepared in step 4 into a 20 mL syringe. Withdraw the labelled cell suspension into the same syringe, leaving a residual volume of 0.2 - 0.5 mL in the tube. (This residue will contain any clumps of leucocytes which have settled during incubation and should be discarded.) Remove the syringe needle and transfer the syringe contents to another 15 mL conical tube. 12. Centrifuge the capped tube at 80 - 90g for 7 minutes. Decant the supernatant and resuspend the cell pellet in 10 mL saline as described in step 6. 13. Withdraw the remaining volume of platelet-poor plasma (step 4) into a fresh 20 mL syringe and withdraw the 111 In-labelled cell suspension into the same syringe. Measure the total activity present and if necessary discard any excess volume to leave the required patient dose. 14. Administer the 111 In -labelled leucocyte suspension by slow intravenous injection using a 19G needle. PROCEDURE FOR THE PREPARATION AND ADMINISTRATION OF INDIUM-111 LABELLED PLATELETS Aseptic technique should be used throughout. Good pharmaceutical practice for the preparation of sterile solutions should be followed. All sterile solutions should be freshly prepared. Analytical grade chemicals should be used throughout. This procedure for the Indium-111 labelling of the patient’s own platelets is described by Hawker et al. HAWKER RJ, HAWKER LM and WILKINSON AR. Indium [ 111 In] labelled human platelets: optimal method. Clinical Science. Vol 58, pp243-248, 1980. The procedure takes approximately 1 hour and aseptic technique must be used throughout. PLATELET HANDLING The following general points should be noted in connection with the procedure. (1) Turbulence and frothing during pipetting stages should be particularly avoided, especially when the platelet pellet is resuspended. (2) Damage to platelets may result from sudden temperature changes. (3) Tubes should be kept stoppered whenever possible to avoid pH changes. (4) Platelets should never be passed through a n Read the complete document